Skip to main content

Table 4 Postoperative outcomes. Multivariable logistic regression analysis

From: Short-term postoperative outcomes of gastric adenocarcinoma patients treated with curative intent in low-volume centers

 

OR (95% CI)

p value

Major postoperative morbidity

Age (years)

 

0.029

 < 75 (ref.)

  

 ≥ 75

1.62 (1.05–2.49)

 

Sex

 

0.183

 Men (ref.)

  

 Women

0.76 (0.51–1.14)

 

Location

 

0.293

 GEJ-SIII type (ref.)

  

 Gastric

0.67 (0.32–1.4)

 

ASA score

 

0.24

 I–II (ref.)

  

 III–IV

1.28 (0.85–1.93)

 

Neoadjuvant chemotherapy

 

0.065

 No (ref.)

  

 Yes

0.62 (0.38–1.03)

 

Laparoscopic approach

 

0.005

 No (ref.)

  

 Yes

2.32 (1.29–4.17)

 

Gastrectomy

 

0.005

 Distal subtotal (ref.)

  

 Total

1.86 (1.2–2.86)

 

Lymphadenectomy

 

0.445

 D0–D1 (ref.)

  

 D1+ or more

0.84 (0.53–1.32)

 

90-day postoperative mortality

Age (years)

 

0.027

 < 75 (ref.)

  

 ≥ 75

2.42 (1.15–5.29)

 

ASA score

 

0.093

 I–II (ref.)

  

 III–IV

1.98 (0.89–4.39)

 

Laparoscopic approach

 

0.495

 No (ref.)

  

 Yes

1.43 (0.51–3.97)

 

Gastrectomy

 

0.769

 Distal subtotal (ref.)

  

 Total

0.89 (0.42–1.88)

 

Pulmonay complications

 

< 0.001

 No (ref.)

  

 Yes

8.54 (4.17–17.47)

 

Cardiac complications

 

< 0.001

 No (ref.)

  

 Yes

5.14 (2.09–12.61)

 

Leakage

 

0.003

 No (ref.)

  

 Yes

3.56 (1.56–8.12)

 

Hemorrhage

 

0.013

 No (ref.)

  

 Yes

5.1 (1.4–18.48)

 

Reoperation

 

0.136

 No (ref.)

  

 Yes

1.99 (0.81–4.9)

 
  1. GEJ-SIII type gastroesophageal junction Siewert type III, ASA American Society of Anesthesiologists classification